CSF-1 and its receptor in breast carcinomas and neoplasms of the female reproductive tract

Molecular Reproduction and Development

Volumn 46, Issue 1, 1997, Pages 71-74

  Kacinski, Barry M ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

breast carcinoma; CSF 1; CSF 1R; endometrial carcinoma; ovarian carcinoma

Indexed keywords

COLONY STIMULATING FACTOR 1; COLONY STIMULATING FACTOR RECEPTOR; GLUCOCORTICOID;

ARTICLE; BREAST CARCINOMA; ENDOMETRIUM CANCER; GYNECOLOGIC CANCER; HUMAN; MACROPHAGE ACTIVATION; NONHUMAN; OVARY CARCINOMA; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

BREAST NEOPLASMS; DEXAMETHASONE; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENITAL NEOPLASMS, FEMALE; HORMONES; HUMANS; IN SITU HYBRIDIZATION; MACROPHAGE COLONY-STIMULATING FACTOR; MACROPHAGES; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; RECEPTOR, MACROPHAGE COLONY-STIMULATING FACTOR; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED;

EID: 0031015002     PISSN: 1040452X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2795(199701)46:1<71::AID-MRD11>3.0.CO;2-6     Document Type: Article

References (17)

1. Bauknecht T, Kiechle-Schwarz M, duBois A, Wölfle J, Kacinski B (1994): Expression of transcripts for CSF-1 and for the "macrophage" and "epithelial" isoforms of the CSF-1R transcripts in human ovarian carcinomas. Cancer Detect Prev 18:231-239.
2. Chambers SK, Gertz RD, Ivins CM, Kacinski BM (1995a): The significance of urokinase-type plasminogen activator, its inhibitors, and its receptor in ascites of patients with epithelial ovarian cancer. Cancer 7:1627-1633, 1995.
3. Chambers SK, Wang Y, Gertz RE, Kacinski BM (1995b): Macrophage colony stimulating factor mediates invasion of ovarian cancer cells through urokinase. Cancer Res 55:1578-1585, 1995.
4. Filderman AE, Bruckner A, Kacinski BM, Deng N, Remold HG (1992): Macrophage colony-stimulating factor (CSF-1) enhances invasiveness in CSF-1 receptor-positive carcinoma cell lines. Cancer Res 52:3661-3669.
5. Hakala A, Kacinski BM, Stanley ER, Kohorn E, Puistola U, Risteli J, Risteli L, Tomas C, Kauppila A (1995): Macrophage-colony stimulating factor (CSF-1), a clinically useful tumor marker in endometrial adenocarcinoma. Comparison with CA-125 and aminoterminal propeptide of type III procollagen. Am J Obstet Gynecol 173:112-119.
6. Kacinski BM, Carter D, Mittal K, Kohorn EI, Bloodgood RS, Donahue J, Donofrio L, Edwards R, Schwartz PE, Chambers JT, Chambers SK (1988): High level expression of fms proto-oncogene mRNA is observed in clinically aggressive human endometrial adenocarcinomas. Int J Radiat Oncol Biol Phys 15:823-829.
7. Kacinski BM, Carter D, Kohorn EI, Mittal K, Bloodgood RS, Donahue J, Kramer CA, Fischer D, Edwards R, Chambers SK, Chambers JT, Schwartz PE (1989a): Oncogene expression in vivo by ovarian adenocarcinomas and mixed-mullerian tumors. Yale J Biol Med 62:379-392.
8. Kacinski BM, Stanley ER, Carter D, Chambers JT, Chambers SK, Kohorn EI, Schwartz PE (1989b): Circulating levels of CSF-1 (M-CSF), a lymphohematopoietic cytokine, may be a useful marker of disease status in patients with malignant ovarian neoplasms. Int J Radiat Oncol Biol Phys 17:159-164.
9. Kacinski BM, Bloodgood RS, Schwartz PE, Carter DC, Stanley ER (1989c): The macrophage colony stimulating factor CSF-1 is produced by human ovarian and endometrial adenocarcinoma-derived cell lines and is present at abnormally high levels in the plasma of ovarian carcinoma patients with active disease. In: "Molecular Diagnostics of Human Cancer." Ca. Cells 7 Cold Spring Harbor, NY: Cold Spring Harbor Press, pp 333-337.
10. Kacinski BM, Carter D, Mittal K, Yee LD, Scata KA, Donofrio L, Chambers SK, Wang K-I, Yang-Feng T, Rohrschneider LR, Rothwell V (1990a): Ovarian adenocarcinomas express fms-complementary transcripts and antigen, often with co-expression of CSF-1. Am J Pathol 137:135-147.
11. Kacinski BM, Chambers SK, Stanley ER, Carter DC, Tseng P, Scata KA Chang DH-Y, Pirro MH, Nguyen JT, Ariza A, Rohrschneider LR, Rothwell V (1990b): The cytokine CSF-1 (M-CSF), expressed by endometrial carcinomas in vivo and in vitro, may also be a circulating tumor marker of neoplastic disease activity in endometrial carcinoma patients. Int J Radiat Oncol Biol Phys 19:619-626.
12. Kacinski BM, Chambers SK, Carter D, Filderman AE, Stanley ER (1990c): The macrophage colony stimulating factor CSF-1, an auto- and paracrine tumor cytokine, is also a circulating "tumor marker" in patients with ovarian, endometrial and pulmonary neoplasms. In CA Dinarello, MJ Kluger, MC Powanda, JJ Oppenheim (eds): "The Physiological and Pathological Effects of Cytokines." New York: Wiley-Liss, Prog Leuk Biol 10B:393-400.
13. Kacinski BM, Scata KA, Carter D, Yee LD, Sapi E, King BL, Chambers SK, Jones MA, Pirro MH, Stanley ER, Rohrschneider LR (1991): FMS (CSF-1 receptor) and CSF-1 transcripts and protein are expressed by human breast carcinomas in vivo and in vitro. Oncogene 6:941-952.
14. Kommoss F, Wölfle J, Bauknecht T, Pfisterer J, Kiechle-Schwartz M, Pfleiderer A, Sauerbrei W, Kiehl R, Kacinski BM (1994): Co-expression of M-CSF transcripts and protein, FMS (M-CSF receptor) transcripts and protein, and steroid receptor content in adenocarcinomas of the ovary. J Pathol 174:111-119.
15. Price FV, Chambers SK, Chambers JT, Carcangiu M-L, Schwartz PE, Kohorn EI, Stanley ER, Kacinski BM (1993): Colony-stimulating factor-1 in primary ascites of ovarian cancer is a significant predictor of survival. Am J Obstet Gynecol 168:520-527.
16. Sapi E, Flick MB, Gilmore-Hebert M, Rodov S, Kacinski BM (1995): Transcriptional regulation of the c-fms (CSF-1r) proto-oncogene in human breast carcinoma cells by glucocorticoids. Oncogene 10: 529-542.
17. Tang R, Kacinski BM, Validire P, Beuvon F, Sastre X, Benoit P, de la Rochefordière A, Mosseri V, Pouillart P, Scholl S (1990): Oncogene amplification correlates with dense lymphocyte infiltration in human breast cancers: A role for hematopoietic growth factor release by tumor cells? J Cell Biochem 44:189-198.